The implantable cardioverter-defibrillator (ICD) is a battery-operated device that is inserted under the skin of the patient to assess and monitor the user’s heart rate. ICDs are connected to heart by wires and if abnormal heart beat is detected, the device delivers an instant electric shock to reinstate a normal heart rhythm. Furthermore, there have been several studies that exhibit that ICDs could prevent cardiac arrest in patients who are at the high risk of life-threatening ventricular arrhythmias. An implantable cardioverter -defibrillator senses when the heart rhythm is not normal and it tries to make the heart rhythm normal. If the device has a pacemaker feature incorporated, it works as a pacemaker when the heartbeat is slow, and transmit tiny electric signals to the heart. However, when the heartbeat is very chaotic or fast, the device gives defibrillation shocks in order to restrain the abnormal rhythm. Implantable cardioverter-defibrillators work for 24 hours a day.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/223
According to Centers for Disease Control and Prevention (CDC), it is estimated that around 2.7–6.1 million individuals in the U.S. suffered from atrial fibrillation in 2015. The report suggests that the number of occurrences is likely to increase with the increase in number of aging of the population in this region. Roughly 2% of the population who are younger than 65 years of age suffers from AF. However, around 9% of the population with 65 years of age or more suffers from AF. Increasing cases of AF among the global population coupled with advancement in technology will drive the implantable cardioverter-defibrillators market during the forecast period.
Implantable Cardioverter-defibrillators Market Taxonomy
On the basis of type of product, the global market is classified into:
Biventricular Implantable Cardioverter Defibrillators
On the basis of type of procedure, the global market is classified into:
Subcutaneous Implantable Cardioverter Defibrillators
Trans-Venous Implantable Cardioverter Defibrillators
On the basis of end user, the global market is classified into:
Ambulatory Surgical Centers
Rising prevalence of arrhythmia is expected to drive growth of the global implantable cardioverter-defibrillators market during the forecast period. Unhealthy dietary habits and lack of adequate exercise could result in high heart-related diseases typically arrhythmia. The demand for ICDs is rising significantly as healthcare professionals and the governing bodies such as American Heart Association have widely accepted this form of treatment due to its safety, and efficacy. However, the AHA recommends that the arrhythmia in question ought to be life threatening for the patient to be eligible for a cardioverter defibrillator.
Among regions, North America held dominant position in the global implantable cardioverter-defibrillator market. This is owing to the presence of constructive policies and regulations along with robust healthcare facilities in the region.
Some of the key players operating in the global implantable cardioverter-defibrillators market are Imricor Medical Systems, Boston Scientific Corporation, Inc., LivaNova PLC Company, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, St. Jude Medical, Inc., and MRI Interventions, Inc.
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/223
Major companies in the market are focused on various business strategies such as merger and acquisition, in order to gain competitive edge in the global market. For instance, in April 2018, MicroPort Scientific Corporation, a medical device developer, acquired Cardiac Rhythm Management (CRM) Business from LivaNova Plc. Upon acquisition CRM Business is now renamed as MicroPort CRM.
Key players in the market are involved in various growth strategies such as research and development, in order to expand their product portfolio. For instance, in May 2019, Medtronic plc, a medical device manufacturer, announced pilot study results for its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD). In this device, the lead is placed outside the heart and veins to provide lifesaving defibrillation.
Key players in the market are involved in different growth strategies such as gaining approval from regulatory authorities, in order to expand their product portfolio. For instance, in September 2017, Abbott Laboratories, a pharmaceutical company, received the U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-labeling for one of company’s most widely used implantable cardioverter defibrillator (ICD) and related high voltage.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/223
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Implantable Cardioverter-defibrillators Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Implantable Cardioverter-defibrillators Industry Impact
Chapter 2 Global Implantable Cardioverter-defibrillators Competition by Types, Applications, and Top Regions and Countries
2.1 Global Implantable Cardioverter-defibrillators (Volume and Value) by Type
2.3 Global Implantable Cardioverter-defibrillators (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Implantable Cardioverter-defibrillators Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Implantable Cardioverter-defibrillators Market Analysis
Chapter 6 East Asia Implantable Cardioverter-defibrillators Market Analysis
Chapter 7 Europe Implantable Cardioverter-defibrillators Market Analysis
Chapter 8 South Asia Implantable Cardioverter-defibrillators Market Analysis
Chapter 9 Southeast Asia Implantable Cardioverter-defibrillators Market Analysis
Chapter 10 Middle East Implantable Cardioverter-defibrillators Market Analysis
Chapter 11 Africa Implantable Cardioverter-defibrillators Market Analysis
Chapter 12 Oceania Implantable Cardioverter-defibrillators Market Analysis
Chapter 13 South America Implantable Cardioverter-defibrillators Market Analysis
Chapter 14 Company Profiles and Key Figures in Implantable Cardioverter-defibrillators Business
Chapter 15 Global Implantable Cardioverter-defibrillators Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027